by Dr Sunil Upadhyay – Despite encouraging progress in the early diagnosis and better management outcome of common cancers, a high proportion of patients still present with advanced… read more.
by Dr Sunil Upadhyay – Basal cell carcinoma is the most common malignancy in the world. Its incidence is common in people with fair skin due to excessive… read more.
by Dr Sunil Upadhyay – It would be difficult to imagine how one would treat breast cancer today if it was not for the work and leadership of… read more.
World Health Matters – Australia – by Gary Finnegan – Over the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily… read more.
by Dr. Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre – The ASCO 2011 Annual Meeting took place in early June at the vast McCormick Place Convention Centre… read more.
Up to one-third of cancer patients experience moderate to severe pain.
by Dr Sunil Upadhyay – In 1838 E. S. Hare published work about tumours involving certain nerves.1 However, Henry Pancoast, a radiologist from Philadelphia described the classical clinical… read more.
by Dr Sunil Upadhyay – Advanced non-small cell carcinoma of the lung represents one of the major unmet needs for an effective and prolonged survival outcome. The majority… read more.
by Dr Sunil Upadhyay – A platinum doublet remains the current gold standard in the management of EGFR mutation negative, advanced non-small cell lung cancers. Pemetrexed is the… read more.
Foreward by Dr Sanjay Popat (pictured). The 14th Annual Scientific Meeting of the IASLC has now closed. Held in Amsterdam at the beginning of July 2011, the annual… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
